Search - tctmd.com

Displaying 521 - 540 of 592

Sort: Relevancy | Date

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

L.A. McKeown

December 05, 2012

News Daily News

Una Dosis Alta de Atorvastatina podría prevenir la Lesión Renal inducida por Contraste en las PCI Voluntarias

L.A. McKeown

November 18, 2012

News Daily News

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

L.A. McKeown

November 18, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Daily News

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

L.A. McKeown

October 10, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

News Daily News

Early Invasive Strategy in NSTEMI Patients Improves Survival

September 18, 2012

News Daily News

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

L.A. McKeown

August 15, 2012

News Daily News

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

August 14, 2012

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Las Infecciones tras una PCI Primaria son Raras pero Serias

August 07, 2012

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

HORIZONS-AMI: Resultados Similares con Abciximab y Eptifibatide durante PCI Primaria

July 05, 2012

News Daily News

La Enfermedad Polivascular Empeora el Pronóstico a Largo Plazo de Pacientes NSTEMI

July 03, 2012

News Daily News

RE-LY: El Dabigatran Acorta la Interrupción del Fármaco sin Aumentar los Episodios Hemorrágicos

Jason Kahn

June 22, 2012

Advertisement

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

Una Dosis Alta de Atorvastatina podría prevenir la Lesión Renal inducida por Contraste en las PCI Voluntarias

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Early Invasive Strategy in NSTEMI Patients Improves Survival

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

Indirect Comparisons Show Little Difference Among New Anticoagulants

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Las Infecciones tras una PCI Primaria son Raras pero Serias

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

HORIZONS-AMI: Resultados Similares con Abciximab y Eptifibatide durante PCI Primaria

La Enfermedad Polivascular Empeora el Pronóstico a Largo Plazo de Pacientes NSTEMI

RE-LY: El Dabigatran Acorta la Interrupción del Fármaco sin Aumentar los Episodios Hemorrágicos

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content